Alyeska Investment Group, L.P. Sellas Life Sciences Group, Inc. Call Options Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$1.06 - $1.63 $507,811 - $780,879	479,067 Added 47.91%	1,479,067 $1.76 Million
Q1 2024 May 15, 2024	SELL	$0.51 - $1.55 $140,250 - $426,250	-275,000 Reduced 21.57%	1,000,000 $1.01 Million
Q2 2023 Aug 14, 2023	BUY	$1.35 - $1.8 $371,250 - $495,000	275,000 Added 27.5%	1,275,000 $2 Million
Q1 2023 May 15, 2023	BUY	$1.18 - $3.86 $1.18 Million - $3.86 Million	1,000,000 New	1,000,000 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$3.79 - $10.5 $236,875 - $656,250	62,500 New	62,500 $268,000

7.08M

1.8M

49.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $26.1M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.